Cases of carbapenemase-producing bacteria identified through medical testing in South Gyeongsang rose from 1,340 in 2021 to 2,334 in 2025, a 74.2% increase. Test requests also increased 66.9%, from 1,542 to 2,574, so the rise cannot be attributed solely to wider testing. Separate health agency reporting shows carbapenem-resistant Enterobacteriaceae infections per 100,000 residents increased from 47.5 to 83.2 over the same period.

These organisms may cause pneumonia, urinary infections or sepsis in older adults and long-term patients with weakened immunity, while resistance to multiple antibiotics can make treatment difficult.